Novo CEO pressed by Senate to cut costs of obesity, diabetic issues medication CEO Lars Fruergaard Jørgensen explained to lawmakers the corporate would look at new talks with insurers regarding the listing prices of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. Before https://label-the-figure-with-the38383.alltdesign.com/not-known-factual-statements-about-healthcare-news-50328795